Results 1 to 4 of 4
Page 1 of 1
TypeTitleAuthor(s)YearViews
A multicenter phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group studyYau, TCC; Cheung, FY; Lee, F; Choo, SP; Wong, HYH; Toh, HC; Leung, AK; Chan, P; Yau, TK; Wong, J; Tang, YF; Lau, JSM; Cheung, TT; Fan, ST; Poon, RTP201359
 
Efficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract)Yau, TCC; Chan, P; Cheung, FY; Lee, AS; Yau, TK; Choo, SP; Toh, HC; Leung, AK; Wong, JS; Wong, S; Lau, J; Pang, RWC; Fan, ST; Poon, RTP2011278
 
Phase II trial of sorafenib with capecitabine and oxaliplatin (SECOX) in patients with locally advanced or metastatic hepatocellular carcinomaYau, TCC; Chan, P; Cheung, FY; Lee, AS; Yau, TK; Choo, SP; Lau, J; Wong, JS; Fan, ST; Poon, RTP200946
 
Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: Report of a phase II studyFoo, W; Ngan, RKC; Law, CK; Yiu, HHY; Tse, KC; Lau, WH; Yau, S; Cheung, FY; Chan, TM; Kwok, CH; Chiu, CY; Au, SK2002168
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download